MX387520B - Particulas de nicotina. - Google Patents

Particulas de nicotina.

Info

Publication number
MX387520B
MX387520B MX2018015119A MX2018015119A MX387520B MX 387520 B MX387520 B MX 387520B MX 2018015119 A MX2018015119 A MX 2018015119A MX 2018015119 A MX2018015119 A MX 2018015119A MX 387520 B MX387520 B MX 387520B
Authority
MX
Mexico
Prior art keywords
particles
nicotine particles
liquid mixture
nicotine
liquid
Prior art date
Application number
MX2018015119A
Other languages
English (en)
Spanish (es)
Other versions
MX2018015119A (es
Inventor
Nicolo Volpe
Original Assignee
Philip Morris Products Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris Products Sa filed Critical Philip Morris Products Sa
Publication of MX2018015119A publication Critical patent/MX2018015119A/es
Publication of MX387520B publication Critical patent/MX387520B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX2018015119A 2016-06-30 2017-06-21 Particulas de nicotina. MX387520B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16177156 2016-06-30
PCT/IB2017/053710 WO2018002779A1 (en) 2016-06-30 2017-06-21 Nicotine particles

Publications (2)

Publication Number Publication Date
MX2018015119A MX2018015119A (es) 2019-04-15
MX387520B true MX387520B (es) 2025-03-18

Family

ID=56296658

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018015119A MX387520B (es) 2016-06-30 2017-06-21 Particulas de nicotina.

Country Status (18)

Country Link
US (2) US11458093B2 (https=)
EP (1) EP3478265B1 (https=)
JP (2) JP7471774B2 (https=)
KR (1) KR102559152B1 (https=)
CN (1) CN109310623B (https=)
AU (1) AU2017290610A1 (https=)
BR (1) BR112018075017A2 (https=)
CA (1) CA3023626A1 (https=)
ES (1) ES3005760T3 (https=)
IL (1) IL263340A (https=)
MX (1) MX387520B (https=)
PH (1) PH12018502715A1 (https=)
PL (1) PL3478265T3 (https=)
RU (1) RU2741309C2 (https=)
SG (1) SG11201809630RA (https=)
UA (1) UA126853C2 (https=)
WO (1) WO2018002779A1 (https=)
ZA (1) ZA201807080B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3055891T3 (en) * 2016-06-30 2026-02-16 Philip Morris Products Sa Nicotine particles and compositions
KR20190126772A (ko) * 2017-03-07 2019-11-12 필립모리스 프로덕츠 에스.에이. 흡입 가능한 니코틴 제형, 및 이의 제조 및 사용 방법
UA130281C2 (uk) * 2019-11-14 2026-01-07 Філіп Морріс Продактс С.А. Сухий порошковий склад зі смаком тютюну, спосіб його одержання та порошкова система
ES3040112T3 (en) * 2020-06-15 2025-10-28 Philip Morris Products Sa Anatabine powder compositions
US12594238B2 (en) * 2020-09-03 2026-04-07 Philip Morris Products S.A. Low hygroscopicity active powder compositions
WO2022049488A1 (en) * 2020-09-03 2022-03-10 Philip Morris Products S.A. Spray dried low hygroscopicity active powder compositions
US20220313678A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Spray dried nicotine for inclusion in oral products
USD1081739S1 (en) 2021-04-06 2025-07-01 Altria Client Services Llc Die for gum forming
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product
WO2024090890A1 (ko) * 2022-10-27 2024-05-02 주식회사 케이티앤지 흡입용 저용량 니코틴 건조 분말 조성물
JP2026509962A (ja) * 2022-10-27 2026-03-26 ケーティー アンド ジー コーポレイション 吸入用ニコチン乾燥粉末の製造方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4655231A (en) 1984-01-09 1987-04-07 Advanced Tobacco Products, Inc. Snuff and preparation thereof
JP3388896B2 (ja) * 1994-08-08 2003-03-24 株式会社日立ユニシアオートモティブ 吸入式投薬器
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
CA2231968A1 (en) 1998-03-11 1999-09-11 Smoke-Stop, A Partnership Consisting Of Art Slutsky Method of producing a nicotine medicament
US20120042886A1 (en) 1998-03-11 2012-02-23 Hanna Piskorz Method of producing a nicotine medicament and a medicament made by the method
US8256433B2 (en) 1999-07-16 2012-09-04 Aradigm Corporation Systems and methods for effecting cessation of tobacco use
US20080138398A1 (en) 1999-07-16 2008-06-12 Aradigm Corporation Dual release nicotine formulations, and systems and methods for their use
US6799576B2 (en) 1999-07-16 2004-10-05 Aradigm Corporation System for effecting smoking cessation
US6586008B1 (en) * 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
US6962006B2 (en) * 2002-12-19 2005-11-08 Acusphere, Inc. Methods and apparatus for making particles using spray dryer and in-line jet mill
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
ITMI20051999A1 (it) 2005-10-21 2007-04-22 Eratech S R L Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
FI20060428A7 (fi) 2006-05-03 2007-11-04 Esko Kauppinen Pintamodifioidut aerosolihiukkaset, menetelmä ja laite niiden tuottamiseksi sekä jauheet ja dispersiot jotka sisältävät kyseisiä hiukkasia
US20080286340A1 (en) 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
JP2012509922A (ja) 2008-11-27 2012-04-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規粉末化結晶質吸入薬
PL3111927T3 (pl) 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
CN107596518B (zh) 2012-02-29 2021-04-23 普马特里克斯营业公司 可吸入干粉剂
SE536491C2 (sv) 2012-03-26 2013-12-27 Bionicotine Ab Påse innehållande nikotin och en tuggummikomposition
US20140261474A1 (en) 2013-03-15 2014-09-18 Aradigm Corporation Methods for inhalation of smoke-free nicotine
ITMI20130572A1 (it) 2013-04-10 2014-10-11 Eratech Srl Composizione comprendente almeno due polveri secche ottenute per spray dry per aumentare la stabilita' della formulazione
KR102490695B1 (ko) 2013-05-06 2023-01-19 쥴 랩스, 인크. 에어로졸 장치를 위한 니코틴 염 제제 및 그 방법
CA2944471C (en) * 2014-04-08 2020-03-31 Philip Morris Products S.A. Nicotine formulations and methods of making the same
CA2943746C (en) * 2014-04-28 2023-08-15 Philip Morris Products S.A. Flavoured nicotine powder inhaler

Also Published As

Publication number Publication date
CN109310623B (zh) 2022-10-21
PH12018502715A1 (en) 2019-07-29
BR112018075017A2 (pt) 2019-03-19
ES3005760T3 (en) 2025-03-17
EP3478265B1 (en) 2025-01-01
EP3478265C0 (en) 2025-01-01
US11458093B2 (en) 2022-10-04
AU2017290610A1 (en) 2018-11-15
MX2018015119A (es) 2019-04-15
RU2018144108A3 (https=) 2020-07-30
US20190117567A1 (en) 2019-04-25
CA3023626A1 (en) 2018-01-04
US20230000767A1 (en) 2023-01-05
ZA201807080B (en) 2019-07-31
UA126853C2 (uk) 2023-02-15
EP3478265A1 (en) 2019-05-08
JP7471774B2 (ja) 2024-04-22
JP2019519542A (ja) 2019-07-11
JP7583764B2 (ja) 2024-11-14
SG11201809630RA (en) 2018-11-29
JP2022116082A (ja) 2022-08-09
RU2018144108A (ru) 2020-07-30
IL263340A (en) 2018-12-31
KR20190026655A (ko) 2019-03-13
PL3478265T3 (pl) 2025-04-14
WO2018002779A1 (en) 2018-01-04
US12048762B2 (en) 2024-07-30
RU2741309C2 (ru) 2021-01-25
CN109310623A (zh) 2019-02-05
KR102559152B1 (ko) 2023-07-26

Similar Documents

Publication Publication Date Title
MX387520B (es) Particulas de nicotina.
CL2020000060A1 (es) Compuestos antiproliferativos y métodos para utilizarlos.
CY1123853T1 (el) Ρυθμιστες nrf2
MA40579A (fr) Anticorps anti-cll-1 et immunoconjugués
IL271110A (en) Antibodies specific for flt3 and their uses
CY1121750T1 (el) Cot διαμορφωτες και μεθοδοι χρησης αυτων
EP3672764A4 (en) HIGH-SPEED HANDLING OF NON-UNIFORM OBJECTS
MX374788B (es) Anticuerpos anti-tim3 y metodos de uso.
PL3558339T3 (pl) Multimeryczne polipeptydy modulujące limfocyty t i sposoby ich stosowania
CL2016002764A1 (es) Composiciones y métodos para modular la expresión del factor b del complemento
MX372675B (es) Anticuerpos anti-jagged1 y metodos de uso.
EA201691945A1 (ru) Антитела к гемагглютинину вируса гриппа типа b и способы их применения
MX2016002574A (es) Nuevos moduladores del homologo 6 (sez6) y metodos de uso.
MX385972B (es) Partículas y composiciones de nicotina.
MA45233A (fr) Anticorps anti-gitr et leurs utilisations
DK3710036T3 (da) Stable ascorbic acid compositions and methods of using the same
EP3426297A4 (en) GITR ANTIBODIES, METHODS AND USES
EP3351533A4 (en) BIARY DERIVATIVE AND MEDICAMENT THEREOF
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
PL3423076T3 (pl) Preparaty do stosowania miejscowego zawierające cyklosporynę i ich zastosowania
PL3034562T3 (pl) Pigmenty do uzyskiwania efektów absorbujących o wysokim nasyceniu barwy i wysokiej jasności, sposób ich wytwarzania i ich zastosowanie
UY36500A (es) Composiciones del inhibidor de la nitrificación y métodos de preparación de las mismas
MX2017014745A (es) Aplicador de aspersion en linea para aves con aspersores automaticos de activacion veloz.
EA201890439A1 (ru) ИММУНООНКОЛОГИЧЕСКАЯ МЕЗОДЕРМАЛЬНАЯ КЛЕТКА-ПРЕДШЕСТВЕННИК (ioMP-КЛЕТКА)
MX2016016233A (es) Anticuerpos anti-lgr5 y sus usos.